EBITDA Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual EBITDA in 2023 was 114.62 Billion DKK , up 37.66% from previous year.
Novo Nordisk A/S's latest quarterly EBITDA in 2024 Q2 was 34.37 Billion DKK , down -1.55% from previous quarter.
Novo Nordisk A/S reported an annual EBITDA of 82.04 Billion DKK in 2022, up 21.44% from previous year.
Novo Nordisk A/S reported an annual EBITDA of 65.39 Billion DKK in 2021, up 12.19% from previous year.
Novo Nordisk A/S reported a quarterly EBITDA of 35.32 Billion DKK for 2024 Q1, up 23.91% from previous quarter.
Novo Nordisk A/S reported a quarterly EBITDA of 28.51 Billion DKK for 2023 Q4, down -12.96% from previous quarter.

Annual EBITDA Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual EBITDA of Novo Nordisk A/S (2023 - 1989)

Year	EBITDA	EBITDA Growth
2023	114.62 Billion DKK	37.66%
2022	82.04 Billion DKK	21.44%
2021	65.39 Billion DKK	12.19%
2020	59.27 Billion DKK	4.19%
2019	57.79 Billion DKK	12.95%
2018	51.17 Billion DKK	-1.92%
2017	52.14 Billion DKK	1.06%
2016	51.62 Billion DKK	-1.66%
2015	49.57 Billion DKK	37.79%
2014	37.92 Billion DKK	8.65%
2013	34.29 Billion DKK	8.86%
2012	30.56 Billion DKK	43.82%
2011	24.93 Billion DKK	3.01%
2010	21.25 Billion DKK	19.45%
2009	17.8 Billion DKK	25.69%
2008	14.86 Billion DKK	33.44%
2007	11.97 Billion DKK	0.87%
2006	11.26 Billion DKK	15.86%
2005	10 Billion DKK	9.59%
2004	8.93 Billion DKK	41.05%
2003	8.02 Billion DKK	-0.73%
2002	7.3 Billion DKK	4.23%
2001	6.67 Billion DKK	18.27%
2000	5.27 Billion DKK	2.15%
1999	3.86 Billion DKK	129.68%
1998	2.42 Billion DKK	-9.33%
1997	3.47 Billion DKK	7.15%
1996	3.04 Billion DKK	-17.56%
1995	3.01 Billion DKK	7.9%
1994	2.89 Billion DKK	6.92%
1993	2.74 Billion DKK	178.73%
1992	1.85 Billion DKK	-47.35%
1991	1.99 Billion DKK	26.89%
1990	1.57 Billion DKK	3.36%
1989	1.52 Billion DKK	20.77%

Year	EBITDA	EBITDA Growth
2024 Q2	34.37 Billion DKK	-1.55%
2024 Q1	35.32 Billion DKK	23.91%
2023 Q4	28.51 Billion DKK	-12.96%
2023 Q1	27.57 Billion DKK	167.38%
2023 FY	- DKK	37.66%
2023 Q3	32.75 Billion DKK	22.63%
2023 Q2	26.71 Billion DKK	-3.14%
2022 Q1	21 Billion DKK	52.14%
2022 Q4	10.31 Billion DKK	-56.66%
2022 Q3	23.79 Billion DKK	9.75%
2022 FY	- DKK	21.44%
2022 Q2	21.68 Billion DKK	3.22%
2021 Q1	18.11 Billion DKK	55.13%
2021 Q4	13.8 Billion DKK	-20.59%
2021 Q3	17.38 Billion DKK	8.7%
2021 Q2	15.99 Billion DKK	-11.68%
2021 FY	- DKK	12.19%
2020 Q2	15.09 Billion DKK	-13.28%
2020 Q1	17.4 Billion DKK	82.9%
2020 FY	- DKK	4.19%
2020 Q4	11.67 Billion DKK	-22.68%
2020 Q3	15.1 Billion DKK	0.05%
2019 Q3	15.03 Billion DKK	3.11%
2019 Q1	15.31 Billion DKK	42.84%
2019 Q2	14.57 Billion DKK	-4.79%
2019 Q4	9.51 Billion DKK	-36.69%
2019 FY	- DKK	12.95%
2018 Q4	10.71 Billion DKK	-14.91%
2018 Q3	12.59 Billion DKK	-10.1%
2018 Q2	14.01 Billion DKK	-2.55%
2018 Q1	14.37 Billion DKK	48.47%
2018 FY	- DKK	-1.92%
2017 FY	- DKK	1.06%
2017 Q4	9.68 Billion DKK	-24.05%
2017 Q3	12.75 Billion DKK	-13.09%
2017 Q2	14.67 Billion DKK	1.48%
2017 Q1	14.45 Billion DKK	29.0%
2016 Q2	13.21 Billion DKK	1.99%
2016 Q1	12.95 Billion DKK	109.68%
2016 FY	- DKK	-1.66%
2016 Q3	13.15 Billion DKK	-0.44%
2016 Q4	11.2 Billion DKK	-14.82%
2015 FY	- DKK	37.79%
2015 Q3	12.62 Billion DKK	-3.87%
2015 Q1	14.8 Billion DKK	97.61%
2015 Q4	6.17 Billion DKK	-51.05%
2015 Q2	13.13 Billion DKK	-11.31%
2014 Q1	8.61 Billion DKK	17.12%
2014 FY	- DKK	8.65%
2014 Q4	7.49 Billion DKK	-15.77%
2014 Q3	8.89 Billion DKK	-2.56%
2014 Q2	9.12 Billion DKK	5.92%
2013 FY	- DKK	8.86%
2013 Q3	8.41 Billion DKK	-6.01%
2013 Q1	7.87 Billion DKK	-1.72%
2013 Q2	8.94 Billion DKK	13.6%
2013 Q4	7.35 Billion DKK	-12.5%
2012 FY	- DKK	43.82%
2012 Q3	7.67 Billion DKK	-1.55%
2012 Q2	7.79 Billion DKK	24.54%
2012 Q1	6.26 Billion DKK	11.96%
2012 Q4	8.01 Billion DKK	4.39%
2011 Q3	6.37 Billion DKK	0.3%
2011 FY	- DKK	3.01%
2011 Q4	5.59 Billion DKK	-12.32%
2011 Q2	6.36 Billion DKK	1.68%
2011 Q1	6.25 Billion DKK	7.38%
2010 Q2	5.78 Billion DKK	15.0%
2010 Q1	5.02 Billion DKK	53.53%
2010 Q4	5.82 Billion DKK	1.09%
2010 FY	- DKK	19.45%
2010 Q3	5.76 Billion DKK	-0.35%
2009 Q4	3.27 Billion DKK	-14.18%
2009 FY	- DKK	25.69%
2009 Q2	4.24 Billion DKK	8.37%
2009 Q1	3.91 Billion DKK	12.95%
2009 Q3	3.81 Billion DKK	-10.11%
2008 FY	- DKK	33.44%
2008 Q2	2.76 Billion DKK	1.07%
2008 Q3	3.27 Billion DKK	18.43%
2008 Q4	3.46 Billion DKK	5.79%
2008 Q1	2.73 Billion DKK	949.03%
2007 FY	- DKK	0.87%
2007 Q2	2.75 Billion DKK	26.04%
2007 Q3	2.64 Billion DKK	-3.72%
2007 Q4	261.04 Million DKK	-90.14%
2007 Q1	2.18 Billion DKK	22.44%
2006 Q3	2.45 Billion DKK	-6.84%
2006 Q2	2.63 Billion DKK	8.54%
2006 FY	- DKK	15.86%
2006 Q4	1.78 Billion DKK	-27.34%
2006 Q1	2.42 Billion DKK	29.92%
2005 Q1	1.2 Billion DKK	-26.31%
2005 FY	- DKK	9.59%
2005 Q4	1.86 Billion DKK	-11.22%
2005 Q3	2.1 Billion DKK	-3.75%
2005 Q2	2.18 Billion DKK	81.02%
2004 Q3	1.7 Billion DKK	12.86%
2004 FY	- DKK	41.05%
2004 Q4	1.63 Billion DKK	-3.97%
2004 Q2	1.51 Billion DKK	12.16%
2004 Q1	1.34 Billion DKK	113.58%
2003 Q1	5.11 Billion DKK	140.95%
2003 Q4	-9.92 Billion DKK	-275.21%
2003 Q3	5.66 Billion DKK	3.29%
2003 Q2	5.48 Billion DKK	7.11%
2003 FY	- DKK	-0.73%
2002 FY	- DKK	4.23%
2002 Q2	5.27 Billion DKK	-12.32%
2002 Q1	6.02 Billion DKK	151.82%
2002 Q3	6.44 Billion DKK	22.11%
2002 Q4	-12.49 Billion DKK	-293.91%
2001 Q2	5.74 Billion DKK	7.47%
2001 Q1	5.34 Billion DKK	137.11%
2001 FY	- DKK	18.27%
2001 Q4	-11.61 Billion DKK	-274.63%
2001 Q3	6.65 Billion DKK	15.78%
2000 Q4	-14.4 Billion DKK	-193.88%
2000 FY	- DKK	2.15%
2000 Q3	15.34 Billion DKK	136.62%
2000 Q2	6.48 Billion DKK	16.57%
2000 Q1	5.56 Billion DKK	147.28%
1999 Q1	4.63 Billion DKK	142.23%
1999 FY	- DKK	129.68%
1999 Q4	-11.76 Billion DKK	-302.07%
1999 Q3	5.82 Billion DKK	15.94%
1999 Q2	5.02 Billion DKK	8.45%
1998 FY	- DKK	-9.33%
1998 Q2	4.56 Billion DKK	8.95%
1998 Q1	4.19 Billion DKK	142.09%
1998 Q3	5.03 Billion DKK	10.22%
1998 Q4	-10.96 Billion DKK	-317.84%
1997 Q3	4.31 Billion DKK	4.63%
1997 FY	- DKK	7.15%
1997 Q1	3.62 Billion DKK	141.58%
1997 Q2	4.12 Billion DKK	13.72%
1997 Q4	-9.96 Billion DKK	-330.83%
1996 FY	- DKK	-17.56%
1996 Q4	-8.72 Billion DKK	-337.73%
1996 Q3	3.66 Billion DKK	4.6%
1996 Q2	3.5 Billion DKK	2.12%
1996 Q1	3.43 Billion DKK	140.75%
1995 Q2	3.57 Billion DKK	6.01%
1995 Q1	3.37 Billion DKK	141.51%
1995 Q3	3.21 Billion DKK	-9.94%
1995 FY	- DKK	7.9%
1995 Q4	-8.42 Billion DKK	-361.95%
1994 FY	- DKK	6.92%
1994 Q1	3.11 Billion DKK	144.7%
1994 Q2	3.42 Billion DKK	10.02%
1994 Q3	3.37 Billion DKK	-1.4%
1994 Q4	-8.12 Billion DKK	-340.61%
1993 Q4	-6.96 Billion DKK	-322.29%
1993 Q1	2.62 Billion DKK	138.63%
1993 Q2	3 Billion DKK	14.37%
1993 Q3	3.13 Billion DKK	4.25%
1993 FY	- DKK	178.73%
1992 Q3	2.56 Billion DKK	-8.67%
1992 Q4	-6.79 Billion DKK	-364.96%
1992 Q2	2.8 Billion DKK	5.54%
1992 FY	- DKK	-47.35%
1992 Q1	2.66 Billion DKK	148.56%
1991 Q1	2.27 Billion DKK	145.95%
1991 Q2	2.24 Billion DKK	-1.2%
1991 FY	- DKK	30.17%
1991 Q4	-5.48 Billion DKK	-329.06%
1991 Q3	2.39 Billion DKK	6.4%
1990 Q1	1.94 Billion DKK	143.86%
1990 Q3	2.02 Billion DKK	-0.11%
1990 FY	- DKK	-6.33%
1990 Q4	-4.95 Billion DKK	-344.08%
1990 Q2	2.03 Billion DKK	4.7%
1989 Q3	1.74 Billion DKK	-0.53%
1989 Q1	1.97 Billion DKK	164.62%
1989 FY	- DKK	24.54%
1989 Q4	-4.42 Billion DKK	-353.14%
1989 Q2	1.75 Billion DKK	-11.07%

Peer EBITDA Comparison of Novo Nordisk A/S

Name	EBITDA	EBITDA Difference
ADC Therapeutics SA	-146.76 Million USD	78205.368%
Alto Neuroscience, Inc.	-34.56 Million USD	331761.941%
Annovis Bio, Inc.	-45.03 Million USD	254633.084%
Biohaven Pharmaceutical Holding Company Ltd.	-429.13 Million USD	26811.392%
Ginkgo Bioworks Holdings, Inc.	-821.29 Million USD	14057.138%
Nuvation Bio Inc.	-99.6 Million USD	115189.357%
Nuvation Bio Inc.	-99.6 Million USD	115189.357%
Arcus Biosciences, Inc.	-283 Million USD	40604.947%
Theriva Biologics, Inc.	-19.85 Million USD	577459.726%
Zymeworks Inc.	-129.95 Million USD	88306.009%

Global Stocks Search

Novo Nordisk A/S (NVO)

EBITDA Summary of Novo Nordisk A/S

Annual EBITDA Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual EBITDA of Novo Nordisk A/S (2023 - 1989)

Peer EBITDA Comparison of Novo Nordisk A/S